Stockreport

This Biotech Stock Could Launch Its First CRISPR Drug In 2022 [Investor's Business Daily]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Related news Crispr Therapeutics ( CRSP ) will launch a gene-editing therapy in the U.S. in 2022, an analyst predicted Friday as he initiated coverage of Crispr stock w [Read more]